Comparison tool
Cosyntropin vs Oxytocin side-by-side
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Comparison tool
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Selected (2/4)
Share this peptide comparison
| Property | Cosyntropin | Oxytocin |
|---|---|---|
| Category | Hormonal | Hormonal |
| Also known as | Cortrosyn, ACTH 1-24, Tetracosactide | Pitocin, Syntocinon, The Love Hormone |
| FDA approved | Yes | Yes |
| Clinical status | FDA Approved - Diagnostic use
| FDA approved for labor and postpartum use; other uses remain under research
|
| What to expect | Adrenal function testing, diagnostic use | Social bonding, anxiety, trust, emotional wellbeing |
| How it works | Cosyntropin is the 1-24 amino-acid portion of ACTH, while endogenous ACTH is described as 39 amino acids long. The source reports that this fragment activates the melanocortin-2 receptor on adrenal cortex cells, which can produce a rapid cortisol rise; the diagnostic value comes from observing whether the adrenal response occurs as expected. | Oxytocin acts through the oxytocin receptor, a G-protein-coupled receptor described in the source as present in the uterus, breast tissue, and multiple brain areas including the amygdala. In peripheral tissues, signaling is linked to calcium-mediated uterine contraction and milk ejection. Central effects are described as modulation of fear, reward, and social-attention circuitry, but intranasal research is difficult to interpret because the amount reaching the brain is uncertain and may involve indirect pathways. |
| Typical dosing | Limited community data available · See research protocols | 10-24 IU intranasal as needed · As needed · Intranasal |
| Research dosing | 250 mcg IV/IM (standard) · Single diagnostic dose · IV or intramuscular | 10-40 IU IV for labor · Single dose or short-term use · IV (obstetric); intranasal (research) |
| Typical duration | Single diagnostic dose | Single dose or short-term use |
| Administration | IV or intramuscular | IV in obstetric labeling; intranasal in research contexts |
| Timing | Morning or as directed With or without food | As needed in studied social or bonding contexts With or without food |
| Evidence level | FDA Approved | FDA Approved |
| Possible side effects |
+4 more
|
+4 more
|
| Research summary | The source characterizes cosyntropin as an FDA-approved, clinically established diagnostic agent. It reports a standard adult diagnostic dose of 250 micrograms, also expressed as 0.25 mg, administered IV or intramuscularly. The described testing approach measures serum cortisol before dosing and again at 30 and 60 minutes. A response reaching roughly 18 micrograms per deciliter is described as generally normal, while assay choice can shift thresholds, including lower cutoffs with LC-MS/MS. A weak cortisol rise may support adrenal insufficiency assessment, with the source distinguishing primary adrenal disease from possible secondary or tertiary causes and noting interpretation caveats. The evidence focus is diagnostic accuracy and test interpretation, not therapeutic benefit. | The source treats injectable obstetric oxytocin as established, while describing intranasal behavioral research as contested. For social reward, a 2023 systematic review covering 19 randomized, double-blind, placebo-controlled studies and about 984 participants reported a clearer signal in brain-activity outcomes than in behavior or self-report. In autism research, the source cites a 2021 Scientific Reports randomized trial that did not find a substantial empathy-related neural activation change, and it notes that repeated-dose studies have ranged from modest social-behavior findings to no clear effect. Context and sex-specific differences are presented as important reasons the findings remain difficult to generalize. Short-term intranasal trial safety was described as reassuring, but the source does not establish a reliable clinical benefit for these investigational uses. |
| References | ||
| Full profile | View Details | View Details |
Save this comparison
Keep this research set handy with a free PeptiGuide account.
Save this comparison - free accountTrack your peptide journey
Turn research into a private protocol log when you are ready.
Track your peptide journeyEducational use only. This information is aggregated from public research and community reports. It is not medical advice, and dosing details are descriptive, not recommendations. Always consult a qualified healthcare professional.